Hains, David S.Schwaderer, Andrew L.Carroll, Aaron E.Starr, Michelle C.Wilson, Amy C.Amanat, FatimaKrammer, Florian2020-09-102020-09-102020-05-14Hains, D. S., Schwaderer, A. L., Carroll, A. E., Starr, M. C., Wilson, A. C., Amanat, F., & Krammer, F. (2020). Asymptomatic Seroconversion of Immunoglobulins to SARS-CoV-2 in a Pediatric Dialysis Unit. JAMA. https://doi.org/10.1001/jama.2020.84381538-35980098-7484https://hdl.handle.net/1805/23796This article is made available for unrestricted research re-use and secondary analysis in any form or be any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.Dialysis units are at especially high risk of infectious disease transmission, and concern exists about spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Dialysis units in Wuhan, China, have reported high coronavirus disease 2019 (COVID-19) prevalence, due in part to unique exposure challenges that limit social distancing efforts, including open bay formats and rotating/multiple nursing assignments. This study describes SARS-CoV-2 seroconversion in patients and health care workers in a pediatric dialysis unit.en-USPublic Health EmergencyCOVID-19PediatricsDialysis UnitsCase StudyArticle